US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 82 | 201 | 277 | 3,072 | 6,701 |
| Cost of Goods | 24 | 52 | 64 | 1,335 | 2,111 |
| Gross Profit | 58 | 149 | 213 | 1,737 | 4,590 |
| Operating Expenses | 1,803 | 2,337 | 2,677 | 5,489 | 5,799 |
| Operating Income | -1,721 | -2,136 | -2,400 | -3,417 | -1,098 |
| Interest Expense | 690 | 1,000 | 488 | 981 | 1,445 |
| Other Income | -447 | -151 | -2 | 563 | 382 |
| Pre-tax Income | -2,858 | -3,287 | -2,891 | -3,835 | -2,160 |
| Net Income Continuous | -2,858 | -3,287 | -2,891 | -3,835 | -2,160 |
| Net Income | $-2,858 | $-3,287 | $-2,891 | $-3,835 | $-2,160 |
| EPS Basic Total Ops | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-1,035 | $-1,159 | $-1,953 | $-2,976 | $-695 |